| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 22 |
| 1 | INFLIXIMAB-DYYB | 18 |
| 2 | PREDNISONE | 16 |
| 3 | METHOTREXATE SODIUM | 15 |
| 4 | METHOTREXATE | 13 |
| 5 | DENOSUMAB | 9 |
| 6 | CALCIUM | 8 |
| 7 | FOLIC ACID | 8 |
| 8 | ALENDRONATE SODIUM | 7 |
| 9 | ERGOCALCIFEROL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 18 | 0.0052 |
| 1 | L-TRYPTOPHAN | 1 | 0.0023 |
| 2 | BUPROPION HCL ER | 1 | 0.0021 |
| 3 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 4 | PENICILLIN G SODIUM | 1 | 0.0009 |
| 5 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 6 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 7 | ADALIMUMAB-AFZB | 2 | 0.0007 |
| 8 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 2 | 0.0007 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 1 | Corticosteroid [EPC] | 20 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 4 | Vitamin D [EPC] | 11 |
| 5 | RANK Ligand Inhibitor [EPC] | 9 |
| 6 | Vitamin B12 [EPC] | 9 |
| 7 | Vitamin C [EPC] | 9 |
| 8 | Calcium [EPC] | 8 |
| 9 | Janus Kinase Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 5 | Barbiturate [EPC] | 1 | 0.0001 |
| 6 | Progesterone [EPC] | 2 | 0.0001 |
| 7 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Sympathomimetic-like Agent [EPC] | 2 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 6 | 0.0001 |